Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-12

Clinical Trial Update: Use of Intranasal Oxytocin During Detoxification of Crack Cocaine [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial investigating intranasal oxytocin for cocaine withdrawal and related disorders during detoxification (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • intranasal oxytocin (oxytocin)

Snippet

Sponsor: Pontificia Universidade Católica do Rio Grande do Sul | Conditions: Cocaine Withdrawal, Cocaine Smoking | Phase 1, Phase 2 | Status: UNKNOWN